Differential blood cellular profile in patients with moderate-to-severe psoriasis treated with classical systemic therapies: a step forward in personalized medicine

Br J Dermatol. 2018 Sep;179(3):765-766. doi: 10.1111/bjd.16537. Epub 2018 Jun 21.

Affiliations

¹ Immuno-Rheumatology Research Group, IdiPaz, University Hospital La Paz, Madrid, Spain.
² Department of Immunology, IRYCIS, University Hospital Ramón y Cajal, Madrid, Spain.
³ Department of Dermatology, University Hospital La Paz, Madrid, Spain.

PMID: 29526036
DOI: 10.1111/bjd.16537

No abstract available

Publication types

Letter
Observational Study

MeSH terms

Biological Products / pharmacology*
Biological Products / therapeutic use
Cell Separation / methods
Clinical Decision-Making
Cytokines / metabolism
Dermatologic Agents / pharmacology*
Dermatologic Agents / therapeutic use
Drug Substitution
Flow Cytometry / methods
Follow-Up Studies
Humans
Leukocyte Count
Leukocytes, Mononuclear / drug effects*
Leukocytes, Mononuclear / metabolism
Patient Selection
Prospective Studies
Psoriasis / blood
Psoriasis / diagnosis
Psoriasis / drug therapy*
Severity of Illness Index
Treatment Outcome

Substances

Biological Products
Cytokines
Dermatologic Agents